Lipid peroxidation in cell death

Biochemical and Biophysical Research Communications

Volumn 482, Issue 3, 2017, Pages 419-425

  Gaschler, Michael M ^a   Stockwell, Brent R ^a  

^a Columbia University ^*  (United States)

Author keywords

Antioxidant; Ferroptosis; Lipid oxidation; Neurodegeneration; Oxidation; Peroxidation

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; FERROUS GLUCONATE; HYDROGEN PEROXIDE; LIPID HYDROPEROXIDE; LIPID PEROXIDE; MEMBRANE LIPID; REDUCING AGENT; LIPOXYGENASE INHIBITOR;

ALZHEIMER DISEASE; BIOSYNTHESIS; CELL DEATH; CELL MEMBRANE; DEGENERATIVE DISEASE; FERROPTOSIS; HUMAN; LIPID BILAYER; LIPID DEGRADATION; LIPID PEROXIDATION; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; TOXICITY; ANIMAL; DRUG EFFECTS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; CELL DEATH; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOXYGENASE INHIBITORS; METABOLIC NETWORKS AND PATHWAYS; OXIDATION-REDUCTION; REDUCING AGENTS;

EID: 85012272811     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.10.086     Document Type: Review

References (65)

1. [1] Turini, M.E., DuBois, R.N., Cyclooxygenase-2: a therapeutic target. Annu. Rev. Med. 53 (2002), 35–57.
2. [2] Ricciotti, E., FitzGerald, G.A., Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 986–1000.
3. [3] Higdon, A., Diers, A.R., Oh, J.Y., Landar, A., Darley-Usmar, V.M., Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem. J. 442 (2012), 453–464.
4. [4] Breuer, W., Shvartsman, M., Cabantchik, Z.I., Intracellular labile iron. Int. J. Biochem. Cell Biol. 40 (2008), 350–354.
5. [5] Marisa Repetto, J.S., Boveris, Alberto, Lipid peroxidation: chemical mechanism, biological implications and analytical determination. Catala, D.A., (eds.) Lipid Peroxiation, 2012 InTech2012.
6. [6] Laneuville, O., Breuer, D.K., Xu, N., Huang, Z.H., Gage, D.A., Watson, J.T., Lagarde, M., DeWitt, D.L., Smith, W.L., Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J. Biol. Chem. 270 (1995), 19330–19336.
7. [7] Rouzer, C.A., Matsumoto, T., Samuelsson, B., Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities. Proc. Natl. Acad. Sci. U. S. A. 83 (1986), 857–861.
8. [8] Radmark, O., Arachidonate 5-lipoxygenase. Prostagl. Other Lipid Mediat 68–69 (2002), 211–234.
9. [9] Radmark, O., Werz, O., Steinhilber, D., Samuelsson, B., 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim. Biophys. Acta 1851 (2015), 331–339.
10. [10] Radmark, O., Werz, O., Steinhilber, D., Samuelsson, B., 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. 32 (2007), 332–341.
11. [11] Percival, M.D., Denis, D., Riendeau, D., Gresser, M.J., Investigation of the mechanism of non-turnover-dependent inactivation of purified human 5-lipoxygenase. Inactivation by H2O2 and inhibition by metal ions. Eur. J. Biochem. 210 (1992), 109–117.
12. [12] Peters-Golden, M., Brock, T.G., 5-lipoxygenase and FLAP. Prostagl. Leukot. Essent. Fat. Acids 69 (2003), 99–109.
13. [13] Ackermann, J.A., Hofheinz, K., Zaiss, M.M., Kronke, G., The double-edged role of 12/15-lipoxygenase during inflammation and immunity. Biochim. Biophys. Acta, 2016.
14. [14] Brash, A.R., Boeglin, W.E., Chang, M.S., Discovery of a second 15S-lipoxygenase in humans. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 6148–6152.
15. [15] Dobrian, A.D., Lieb, D.C., Cole, B.K., Taylor-Fishwick, D.A., Chakrabarti, S.K., Nadler, J.L., Functional and pathological roles of the 12- and 15-lipoxygenases. Prog. Lipid Res. 50 (2011), 115–131.
16. [16] Soberman, R.J., Harper, T.W., Betteridge, D., Lewis, R.A., Austen, K.F., Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid omega-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuclear leukocytes. J. Biol. Chem. 260 (1985), 4508–4515.
17. [17] Takahashi, Y., Glasgow, W.C., Suzuki, H., Taketani, Y., Yamamoto, S., Anton, M., Kuhn, H., Brash, A.R., Investigation of the oxygenation of phospholipids by the porcine leukocyte and human platelet arachidonate 12-lipoxygenases. Eur. J. Biochem. 218 (1993), 165–171.
18. [18] Jung, G., Yang, D.C., Nakao, A., Oxygenation of phosphatidylcholine by human polymorphonuclear leukocyte 15-lipoxygenase. Biochem. Biophys. Res. Commun. 130 (1985), 559–566.
19. [19] Friedmann Angeli, J.P., Schneider, M., Proneth, B., Tyurina, Y.Y., Tyurin, V.A., Hammond, V.J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., Basavarajappa, D., Radmark, O., Kobayashi, S., Seibt, T., Beck, H., Neff, F., Esposito, I., Wanke, R., Forster, H., Yefremova, O., Heinrichmeyer, M., Bornkamm, G.W., Geissler, E.K., Thomas, S.B., Stockwell, B.R., O'Donnell, V.B., Kagan, V.E., Schick, J.A., Conrad, M., Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16 (2014), 1180–1191.
20. [20] Yang, W.S., SriRamaratnam, R., Welsch, M.E., Shimada, K., Skouta, R., Viswanathan, V.S., Cheah, J.H., Clemons, P.A., Shamji, A.F., Clish, C.B., Brown, L.M., Girotti, A.W., Cornish, V.W., Schreiber, S.L., Stockwell, B.R., Regulation of ferroptotic cancer cell death by GPX4. Cell 156 (2014), 317–331.
21. [21] Ayala, A., Munoz, M.F., Arguelles, S., Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell Longev., 2014, 2014, 360438.
22. [22] Esterbauer, H., Schaur, R.J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991), 81–128.
23. [23] Spickett, C.M., The lipid peroxidation product 4-hydroxy-2-nonenal: advances in chemistry and analysis. Redox Biol. 1 (2013), 145–152.
24. [24] Schneider, C., Tallman, K.A., Porter, N.A., Brash, A.R., Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J. Biol. Chem. 276 (2001), 20831–20838.
25. [25] Schneider, C., Boeglin, W.E., Yin, H., Ste, D.F., Hachey, D.L., Porter, N.A., Brash, A.R., Synthesis of dihydroperoxides of linoleic and linolenic acids and studies on their transformation to 4-hydroperoxynonenal. Lipids 40 (2005), 1155–1162.
26. [26] Del Rio, D., Stewart, A.J., Pellegrini, N., A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc Dis. 15 (2005), 316–328.
27. [27] Schneider, C., Porter, N.A., Brash, A.R., Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J. Biol. Chem. 283 (2008), 15539–15543.
28. [28] Gu, X., Salomon, R.G., Fragmentation of a linoleate-derived gamma-hydroperoxy-alpha,beta-unsaturated epoxide to gamma-hydroxy- and gamma-oxo-alkenals involves a unique pseudo-symmetrical diepoxycarbinyl radical. Free Radic. Biol. Med. 52 (2012), 601–606.
29. [29] Kaur, K., Salomon, R.G., O'Neil, J., Hoff, H.F., (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins. Chem. Res. Toxicol. 10 (1997), 1387–1396.
30. [30] Yin, H.Y., Xu, L.B., Porter, N.A., Free radical lipid peroxidation: mechanisms and analysis. Chem. Rev. 111 (2011), 5944–5972.
31. [31] Mario Diaz, A.C., Editorial: impact of lipid peroxidation on the physiology and pathophysiology of cell membranes. Front. Physiol., 7, 2016.
32. [32] Wong-Ekkabut, J., Xu, Z., Triampo, W., Tang, I.M., Tieleman, D.P., Monticelli, L., Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys. J. 93 (2007), 4225–4236.
33. [33] Li, X.M., Salomon, R.G., Qin, J., Hazen, S.L., Conformation of an endogenous ligand in a membrane bilayer for the macrophage scavenger receptor CD36. Biochemistry 46 (2007), 5009–5017.
34. [34] Borst, J.W., Visser, N.V., Kouptsova, O., Visser, A.J., Oxidation of unsaturated phospholipids in membrane bilayer mixtures is accompanied by membrane fluidity changes. Biochim. Biophys. Acta 1487 (2000), 61–73.
35. [35] Heffern, C.T., Pocivavsek, L., Birukova, A.A., Moldobaeva, N., Bochkov, V.N., Lee, K.Y., Birukov, K.G., Thermodynamic and kinetic investigations of the release of oxidized phospholipids from lipid membranes and its effect on vascular integrity. Chem. Phys. Lipids 175–176 (2013), 9–19.
36. [36] Gurbuz, G., Heinonen, M., LC-MS investigations on interactions between isolated beta-lactoglobulin peptides and lipid oxidation product malondialdehyde. Food Chem. 175 (2015), 300–305.
37. [37] Reilly, C.A., Aust, S.D., Measurement of lipid peroxidation. Curr. Protoc. Toxicol., 2001 (Chapter 2) Unit 2 4.
38. [38] Yan, L.J., Forster, M.J., Chemical probes for analysis of carbonylated proteins: a review. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879 (2011), 1308–1315.
39. [39] Braughler, J.M., Duncan, L.A., Chase, R.L., The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J. Biol. Chem. 261 (1986), 10282–10289.
40. [40] Niki, E., Biomarkers of lipid peroxidation in clinical material. Biochim. Biophys. Acta 1840 (2014), 809–817.
41. [41] Chen, C.T., Green, J.T., Orr, S.K., Bazinet, R.P., Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostagl. Leukot. Essent. Fat. Acids 79 (2008), 85–91.
42. [42] Dalleau, S., Baradat, M., Gueraud, F., Huc, L., Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 20 (2013), 1615–1630.
43. [43] Yang, W.S., Stockwell, B.R., Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 26 (2016), 165–176.
44. [44] Citron, M., Alzheimer's disease: strategies for disease modification. Nat. Rev. Drug Discov. 9 (2010), 387–398.
45. [45] Huang, X., Atwood, C.S., Hartshorn, M.A., Multhaup, G., Goldstein, L.E., Scarpa, R.C., Cuajungco, M.P., Gray, D.N., Lim, J., Moir, R.D., Tanzi, R.E., Bush, A.I., The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38 (1999), 7609–7616.
46. [46] Pratico, D., Zhukareva, V., Yao, Y., Uryu, K., Funk, C.D., Lawson, J.A., Trojanowski, J.Q., Lee, V.M., 12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am. J. Pathol. 164 (2004), 1655–1662.
47. [47] Succol, F., Pratico, D., A role for 12/15 lipoxygenase in the amyloid beta precursor protein metabolism. J. Neurochem. 103 (2007), 380–387.
48. [48] Arlt, S., Muller-Thomsen, T., Beisiegel, U., Kontush, A., Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease. Neurochem. Res. 37 (2012), 2706–2714.
49. [49] Tolonen, M., Halme, M., Sarna, S., Vitamin E and selenium supplementation in geriatric patients: a double-blind preliminary clinical trial. Biol. Trace Elem. Res. 7 (1985), 161–168.
50. [50] Galasko, D.R., Peskind, E., Clark, C.M., Quinn, J.F., Ringman, J.M., Jicha, G.A., Cotman, C., Cottrell, B., Montine, T.J., Thomas, R.G., Aisen, P., S. Alzheimer's Disease Cooperative. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch. Neurol. 69 (2012), 836–841.
51. [51] Persson, T., Popescu, B.O., Cedazo-Minguez, A., Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?. Oxid. Med. Cell Longev., 2014, 2014, 427318.
52. [52] Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., Patel, D.N., Bauer, A.J., Cantley, A.M., Yang, W.S., Morrison, B. 3rd, Stockwell, B.R., Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149 (2012), 1060–1072.
53. [53] Yang, W.S., Kim, K.J., Gaschler, M.M., Patel, M., Shchepinov, M.S., Stockwell, B.R., Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E4966–E4975.
54. [54] Krainz, T., Gaschler, M.M., Lim, C., Sacher, J.R., Stockwell, B.R., Wipf, P., A mitochondrial-targeted nitroxide is a potent inhibitor of ferroptosis. ACS Cent. Sci. 2 (2016), 653–659.
55. [55] Steinhilber, D., Hofmann, B., Recent advances in the search for novel 5-lipoxygenase inhibitors. Basic Clin. Pharmacol. Toxicol. 114 (2014), 70–77.
56. [56] Bell, R.L., Young, P.R., Albert, D., Lanni, C., Summers, J.B., Brooks, D.W., Rubin, P., Carter, G.W., The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor. Int. J. Immunopharmacol. 14 (1992), 505–510.
57. [57] Young, R.N., Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized?. Eur. J. Med. Chem. 34 (1999), 671–685.
58. [58] Kenyon, V., Rai, G., Jadhav, A., Schultz, L., Armstrong, M., Jameson, J.B. 2nd, Perry, S., Joshi, N., Bougie, J.M., Leister, W., Taylor-Fishwick, D.A., Nadler, J.L., Holinstat, M., Simeonov, A., Maloney, D.J., Holman, T.R., Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase. J. Med. Chem. 54 (2011), 5485–5497.
59. [59] Eleftheriadis, N., Neochoritis, C.G., Leus, N.G., van der Wouden, P.E., Domling, A., Dekker, F.J., Rational development of a potent 15-Lipoxygenase-1 inhibitor with in vitro and ex vivo anti-inflammatory properties. J. Med. Chem. 58 (2015), 7850–7862.
60. [60] Hill, S., Lamberson, C.R., Xu, L., To, R., Tsui, H.S., Shmanai, V.V., Bekish, A.V., Awad, A.M., Marbois, B.N., Cantor, C.R., Porter, N.A., Clarke, C.F., Shchepinov, M.S., Small amounts of isotope-reinforced polyunsaturated fatty acids suppress lipid autoxidation. Free Radic. Biol. Med. 53 (2012), 893–906.
61. [61] Andreyev, A.Y., Tsui, H.S., Milne, G.L., Shmanai, V.V., Bekish, A.V., Fomich, M.A., Pham, M.N., Nong, Y., Murphy, A.N., Clarke, C.F., Shchepinov, M.S., Isotope-reinforced polyunsaturated fatty acids protect mitochondria from oxidative stress. Free Radic. Biol. Med. 82 (2015), 63–72.
62. [62] Cotticelli, M.G., Crabbe, A.M., Wilson, R.B., Shchepinov, M.S., Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids. Redox Biol. 1 (2013), 398–404.
63. [63] Maiorino, M., Roveri, A., Coassin, M., Ursini, F., Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51). Biochem. Pharmacol. 37 (1988), 2267–2271.
64. [64] Takebe, G., Yarimizu, J., Saito, Y., Hayashi, T., Nakamura, H., Yodoi, J., Nagasawa, S., Takahashi, K., A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J. Biol. Chem. 277 (2002), 41254–41258.
65. [65] Niki, E., Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic. Biol. Med. 66 (2014), 3–12.